The authors concluded that the antagonism of cannabinoid receptors might be effective in reducing impulsive symptoms present in ADHD, since WIN55212-2 decreased the choices of the large reward, suggesting that CB1R plays a relevant role in impulsive behavior. Here, CNR1 is linked to attention deficit-hyperactivity disorder.